Compliance for Investigational Medicinal Products (IMPs)
Our in-depth understanding of the pharmaceutical industry regulations supports every phase of clinical trial management. Our IMP compliance services include:
Gap Analyses and Benchmarking
We provide expertise in Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP), assisting with the interpretation and practical application of these essential frameworks to guarantee compliance across your clinical trial processes.
Data Integrity Assurance
Clarion Quality implements data management protocols that meet international expectations for integrity, traceability, and reliability, minimising data risks and reinforcing regulator confidence.
International Regulatory Alignment
With extensive exposure to cross-border clinical trial requirements, we guide clients to align their operations with global standards, reducing the risk of costly non-compliance throughout the drug development journey.
Risk-Based Approach
Our consultants identify essential compliance priorities and manage the application of best practices for IMPs, protecting patient safety while optimising regulatory outcomes for your organisation.
Inspection Readiness for Trial Sites
Clarion Quality helps ensure your trial sites always meet regulatory expectations by providing:
MHRA & Regulatory Inspection Preparation
We keep your teams prepared for inspections from the Medicines & Healthcare products Regulatory Agency (MHRA) and other authorities, offering extensive documentation reviews and practical pre-inspection support.
Documentation Management
Our consultants create and refine your Standard Operating Procedures (SOPs), training logs, and essential records, ensuring accurate, well-maintained documentation to withstand regulator scrutiny.
Staff Training
We deliver targeted, helpful training to staff members, building understanding and promoting a quality culture that drives ongoing compliance at every level of study conduct.
Risk Reduction Strategies
Clarion Quality identifies and addresses potential compliance gaps early, minimising disruption and safeguarding trial continuity under regulatory review.
Quality Oversight for Clinical Operations
Our quality oversight supports trial integrity and compliance from protocol development to reporting:
- Process Supervision: Expert guidance to monitor clinical trial processes, from planning and execution through final data reporting, resulting in consistently compliant outcomes.
- Regulatory Recordkeeping: We ensure records like case report forms and informed consent documents are accurate, accessible, and satisfy all regulatory requirements.
- Performance Reviews: Regular site assessments identify strengths and highlight improvement opportunities, helping clinical teams achieve and sustain quality benchmarks demanded by regulators.
Ethical Governance: Clarion Quality's approach integrates ethical leadership, promoting not only regulatory compliance but also patient welfare and integrity throughout all trial phases.
Bridging GMP, GCP, and Regulatory Requirements
We offer specialist support for managing the vital interface between manufacturing, laboratory, and clinical domains, with:
- Integrated Quality Systems: Development and optimisation of Pharmaceutical Quality Systems (PQS) and Laboratory Quality Systems (LQS) to bridge GMP and GCP requirements, creating a seamless flow of compliance between functions.
- Interdepartmental Collaboration: Facilitating communication and knowledge transfer between laboratory, manufacturing, and clinical teams, ensuring requirements for investigational medicinal products are clear and consistently met.
- Regulatory Gap Analysis: Clarion Quality identifies compliance gaps at the intersection of production and clinical environments and offers practical recommendations to close them.
- Patient-Centric Safety Measures: Our oversight ensures regulatory expectations and patient safety remain top priorities, supporting successful outcomes and prompt, compliant regulatory submissions.
Frequently Asked Questions
What compliance standards apply to clinical trials?
Clinical trials in the UK must comply with Good Clinical Practice (GCP), Good Manufacturing Practice (GMP), and all applicable MHRA and international regulations.
What is GMP Annex 13 for investigational medicinal products?
GMP Annex 13 outlines requirements for the manufacture, quality control, and labelling of investigational medicinal products (IMPs) used in clinical trials.
How do GMP and GCP overlap in clinical trials?
GMP ensures the quality of IMP manufacturing, while GCP governs trial conduct and data integrity. Both ensure patient safety and regulatory compliance throughout the trial.
What audits are required for clinical trial supply chains?
Audits for clinical trial supply chains verify GCP and GMP compliance, assess supplier quality systems, and review documentation for regulatory adherence.
How can organisations ensure compliance when importing investigational medicinal products?
Organisations must follow GMP Annex 13, perform quality checks, maintain documentation, and adhere to MHRA import regulations for IMP compliance.
What role does quality management play in clinical trials?
Quality management provides oversight of processes, ensures regulatory and ethical standards are met, and supports continuous improvement for clinical trial success.
Get in Touch
Partner with Clarion Quality to ensure your clinical trial compliance, from auditing to training and GMP consultancy. To book our expert services, contact us today.
Services

Clarion Quality GXP UK Limited - Company number 12675976 - Registered in England & Wales